interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Sebetralstat

Generic competition · all medicines · read 12 November 2026

Is there a generic of Sebetralstat, and who makes it?

Sebetralstat appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Sebetralstat1 dosage-form group in the Orange Book
0generic makers listed
  1. Sebetralstat appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Ekterly. No generic is listed as marketed.

2020202520302035204001brand 2025data datePatent 11198691 listed to expire 26 November 2035Patent 11084809 listed to expire 26 November 2035Patent 10611758 listed to expire 26 November 2035Patent 10364238 listed to expire 26 November 2035Patent 11001578 listed to expire 26 November 2035Patent 11739068 listed to expire 23 June 2037Patent 11230537 listed to expire 25 December 2037Patent 11234939 listed to expire 26 January 2039Exclusivity NCE to 3 July 2030Exclusivity ODE-534 to 3 July 2032
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 3 July 2030Exclusivity NCE Ekterly
  • 3 July 2032Exclusivity ODE-534 Ekterly
  • 26 November 2035Patent 11198691
  • 26 November 2035Patent 11084809 drug substance
  • 26 November 2035Patent 10611758
  • 26 November 2035Patent 10364238 drug substance
  • 26 November 2035Patent 11001578 drug substance
  • 23 June 2037Patent 11739068
  • 25 December 2037Patent 11230537 drug substance
  • 26 January 2039Patent 11234939 drug product

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.